Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

671
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
671
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

964
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
964
Teratogenicity01:07

Teratogenicity

4.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Physiological Barriers01:25

Physiological Barriers

5.0K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.0K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
Ethical Standards II01:23

Ethical Standards II

1.2K
Ethical standards are the backbone of nursing practice, guiding nurses as they interact with patients, families, and colleagues. These standards are crucial for providing safe, empathetic care centered on the patient's needs.
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strategies to recruit and retain Black and Latina/x women and birthing people in a biospecimen research study.

Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives·2026
Same author

Alcohol and pregnancy: Benefits and harms of pregnancy-specific alcohol policies among maternal-infant dyads covered by Medicaid.

Drug and alcohol dependence·2026
Same author

Examining the association between prior medical mistreatment and interest in and support for over-the-counter medication abortion among people seeking in-person abortion in the United States.

BMC health services research·2026
Same author

Correction: Revisionist History is Not Helpful. A Response to Allen, et al., MCH and Abortion: Toward a Stronger Relationship.

Maternal and child health journal·2026
Same author

Revisionist History is Not Helpful. A Response to Allen, et al., MCH and Abortion: Toward a Stronger Relationship.

Maternal and child health journal·2026
Same author

Oxytocin and Vasopressin Cross Talk Within the Brain Increases Blood Pressure.

Circulation research·2026

Related Experiment Video

Updated: Jan 15, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

609

Mistrust Limits Possibilities for Patient-Provider Discussions Regarding Cannabis Use During Pregnancy.

Heather Gould1, Claudia Zaugg1, Karen A Scott2

  • 1Advancing New Standards in Reproductive Health, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, Oakland, California.

Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health
|October 11, 2025
PubMed
Summary

Pregnant individuals often use cannabis for medical reasons but fear judgment and reporting by healthcare providers. This disconnect hinders open discussions about cannabis risks and benefits during pregnancy.

More Related Videos

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

800
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.5K

Related Experiment Videos

Last Updated: Jan 15, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

609
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

800
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.5K

Area of Science:

  • Perinatal Health
  • Cannabis Research
  • Patient-Provider Communication

Background:

  • Cannabis use during pregnancy is increasing amid policy changes.
  • Healthcare providers are recommended to discuss cannabis use with pregnant patients.

Purpose of the Study:

  • To explore pregnant individuals' perceptions of healthcare provider interactions regarding cannabis use.
  • To understand patient experiences with communication about cannabis during pregnancy.

Main Methods:

  • In-depth interviews with 34 individuals who were pregnant or recently pregnant and used cannabis.
  • Exploration of communication experiences and perspectives with healthcare providers.

Main Results:

  • Most participants did not have providers initiate discussions about cannabis use and few disclosed their use.
  • Participants distrusted providers for cannabis information, fearing judgment and child welfare reporting.
  • Patients perceived providers as equating cannabis with other illicit drugs, disregarding perceived lack of evidence on pregnancy risks.

Conclusions:

  • A disconnect exists between pregnant individuals using cannabis for medical reasons and providers viewing it as a harmful recreational drug.
  • Fear of judgment and reporting by providers limits effective, person-centered discussions on managing pregnancy symptoms and conditions with cannabis.